Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-09-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 65,105
2020-09-01 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −1,563 43,750
2020-08-24 Taylor Stacy L SVP and General Counsel Option exercise +1,109 $7.80 $9K 2,409
2020-08-24 Taylor Stacy L SVP and General Counsel Option exercise +1,771 $6.55 $12K 4,180
2020-08-24 Taylor Stacy L SVP and General Counsel Sale −1,260 $42.07 $53K 2,920
2020-08-24 Taylor Stacy L SVP and General Counsel Sale −1,400 $42.92 $60K 1,520
2020-08-24 Taylor Stacy L SVP and General Counsel Sale −220 $43.36 $10K 1,300
2020-08-24 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,109 37,254
2020-08-24 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,771 33,646
2020-08-21 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-08-21 ROBINS HARLAN S Chief Scientific Officer Sale −350 $42.58 $15K 11,429
2020-08-21 ROBINS HARLAN S Chief Scientific Officer Sale −10,750 $43.14 $464K 679
2020-08-21 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 333,600
2020-08-20 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-08-20 ROBINS HARLAN S Chief Scientific Officer Sale −6,470 $42.63 $276K 5,309
2020-08-20 ROBINS HARLAN S Chief Scientific Officer Sale −4,630 $43.35 $201K 679
2020-08-20 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 344,700
2020-08-19 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-08-19 ROBINS HARLAN S Chief Scientific Officer Sale −4,200 $41.77 $175K 7,579
2020-08-19 ROBINS HARLAN S Chief Scientific Officer Sale −6,900 $42.91 $296K 679

Page 93 of 120 · 2,386 trades